missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Adalimumab Recombinant Human Monoclonal Antibody (D2E7 (Adalimumab))
Human Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA548047
This item is not returnable.
View return policy
Description
Specificity: Binds to soluble TNF-alpha, but not to lymphotoxin (TNF beta).
Adalimumab (Humira) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. Adalimumab binds to the TNF alpha (tumor necrosis factor-alpha), and blocks its interaction with TNF alpha receptors, reducing the inflammatory response of autoimmune diseases.
Specifications
| Adalimumab | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% ProClin 300 | |
| Human | |
| Protein A | |
| RUO | |
| Human, Mouse | |
| Antibody | |
| IgG1 κ |
| ELISA, Inhibition Assays, Immunohistochemistry, Immunocytochemistry | |
| D2E7 (Adalimumab) | |
| Unconjugated | |
| D2E7; Humira | |
| This antibody was generated by affinity maturation from the 2SD4 scFv, which in turn was selected on human TNF alpha by guided phage-display technology, using the murine anti-hTNF alpha antibody Mab32 as a template. | |
| 200 μg | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction